Fascia Iliaca Block Supplemented With Perineural Vs Intravenous Dexamethasone (Interventional)
Postoperative Pain
About this trial
This is an interventional treatment trial for Postoperative Pain
Eligibility Criteria
Inclusion Criteria: • Age 2 -12 years.
- ASA I - II
- Scheduled for split thickness grafting.
- Availability and suitability of lateral and anterior aspects of the thigh as a donor site.
Exclusion Criteria:
- Patient's guardian refusal to participate in the study.
- Known allergy to local anesthetics
- Children known to be diabetic.
- Coagulopathy.
- Children with motor or sensory deficits in lower extremities.
- Children who are morbidly obese (BMI≥35) because ultrasound guided regional anesthesia could be technically difficult.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Placebo Comparator
Group1
Group2
Group3
will include 33 patients: each one will receive US guided fascia-iliaca block with 0.7 ml/kg of bupivacaine 0.25% plus 2 ml of normal saline perinural plus 0.15 mg/kg dexamethasone (maximum of 4 mg) in 2 ml volume intravenously.
will include 33 patients: each one will receive US guided fascia-iliaca block with 0.7 ml/kg of bupivacaine 0.25% plus 0.15 mg/kg dexamethasone (maximum of 4 mg) in 2 ml volume perinural plus 2 ml of normal saline intravenously.
will include 33 patients: each one will receive US guided fascia-iliaca block with 0.7 ml/kg of bupivacaine 0.25% plus 2 ml of normal saline perinural plus 2 ml of normal saline intravenously.